Valeo Financial Advisors »

An2 Therapeutics shares owned by Valeo Financial Advisors

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Valeo Financial Advisors from 13F filings

Historical chart of Valeo Financial Advisors investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Valeo Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Valeo Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $12k 10k 1.14

More positions owned by Valeo Financial Advisors

Spdr S&p 500 Etf Etf (SPY)
Ishares S&p Smallcap 600 Etf Etf (IJR)
Ishares Core S&p Mid Cap Etf Etf (IJH)
Ishares Core Msci Emerging Mkts Etf (IEMG)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Eli Lilly & Co Stock (LLY)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Nvidia Corp Stock (NVDA)
Prologis Share Beneficial Int Reit (PLD)
Vanguard Intermediate-term Treasury Etf Etf (VGIT)
Microsoft Stock (MSFT)
Fidelity Total Bond Etf Etf (FBND)
Google Stock (GOOGL)

View all positions for Valeo Financial Advisors

Top funds holding An2 Therapeutics

Almitas Capital
Vanguard Group
Pfizer
Stonepine Capital Management
Peapod Lane Capital
Bank of Nova Scotia
Landscape Capital Management
Renaissance Technologies
BlackRock
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Woodline Partners
State Street Corporation
Rangeley Capital

View all funds holding An2 Therapeutics